Effect of neutropenia with adjuvant epirubicin-CMF on survival in patients with node-negative or 1 to 3 node-positive rapidly proliferating breast cancer. This is an ASCO Meeting Abstract from the ...

Skipping standard axillary lymph node dissection led to very low rates of axillary recurrence in patients with node-positive breast cancer who became node-negative following neoadjuvant chemotherapy, ...

"In addition, survival rates after 44 months in these patients were excellent," said Dr Van Hemert. "The overall survival rate was 95%, and 89% of patients survived without a recurrence of invasive ...

Andrew M. Kaunitz, MD: Several weeks ago, I saw a new patient, a woman in her early 50s who reported "swelling in my armpit." In the past week, she had noted that tissue in the upper outer quadrant of ...

Left: Transverse image of left axilla on initial breast ultrasound, 19 days after first dose of Pfizer COVID-19 vaccination to left upper extremity, demonstrates increased cortical thickness of 4 mm ...

A, right, and B, left, mediolateral oblique views obtained 2 days after booster dose of Pfizer COVID-19 vaccine administered in left upper extremity shows left axillary lymphadenopathy. No right ...

A study published in the Journal of Clinical Oncology determined that the main risk factor for breast cancer-related lymphedema in patients with positive axillary lymph nodes is the type of axillary ...

A study has shown that lymph node transfer is a viable treatment for the swelling in the affected limb, a condition known as lymphedema, after breast cancer surgery. However, an effective drug to ...